Home » Newsletters » BioWorld Science

BioWorld Science

July 23, 1998

View Archived Issues

New antiasthma drug available for licensing from BTG

Inhaled analgesic available for licensing from BTG

Jenapharm describes scavestrogens, a novel class of nonfeminizing estrogens

Therapeutics for urinary incontinence in development at Dainippon

Sankyo prepares inhibitors of TNF-alpha production

Daiichi team discloses ICAM-1 production inhibitors for inflammatory disorders

Potent erythromycin derivatives for Gram-positive infections discovered by Taisho

Scientists at Takeda disclose inhibitors of Na+/H+ exchange

Novel antiallergic diamide compounds in the pipeline at Kowa

New series of neuroprotective compounds described by Nippon Chemiphar

FDA approves new dose range for Zocor

Use of Anticort in AIDS supported by new study

Nortran initiates phase II trials for local anesthetic

BioLon receives FDA approval

Phase III clinical trial results with galantamine suggest novel mechanism of action

MabThera now available for non-Hodgkin's lymphoma in the U.K.

Bristol-Myers Squibb now marketing Cefzil in U.K.

T-593 undergoes extensive toxicological evaluation

Preclinical activity and resistance profile of S-1153, a new NNRTI

New proton pump inhibitor synthesized and evaluated at Yung-Jin

Zelapar receives approval recommendation in U.K.

First antisense drug recommended for approval by FDA advisory committee

First clinical trial for obstructive sleep apnea completed

Genentech stroke study terminated due to inability to demonstrate clinical benefit

Canadian approval granted for first NNRTI for HIV/AIDS

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...